Bruker BRKR Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Bsi Biospin | $197.5M-26.0% | $267M+27.9% | $208.7M+6.9% | $195.3M-6.0% | $207.8M-23.7% | |
| Bsi Calid | $316.3M-4.6% | $331.6M+6.0% | $312.7M+9.4% | $285.8M+2.0% | $280.1M-12.6% | |
| Bsi Nano | $246M-20.4% | $309.1M+16.0% | $266.5M+5.7% | $252.1M-1.8% | $256.6M-19.4% | |
| Energy And Supercon Technologies | $66.8M-6.6% | $71.5M-3.1% | $73.8M+11.3% | $66.3M+11.8% | $59.3M-17.8% | |
| Revenue by Product | ||||||
| Product And Service Other | $177M-1.6% | $179.9M+6.2% | $169.4M+4.1% | $162.7M+2.9% | $158.1M-7.5% | |
| Product | $646.4M-18.9% | $797.3M+15.4% | $691.1M+8.9% | $634.7M-1.3% | $643.3M-20.4% | |
| Revenue by Geography | ||||||
| Asia Pacific Excluding China | $134.7M-17.4% | $163.1M+24.8% | $130.7M+2.6% | $127.4M-3.0% | $131.4M-20.0% | |
| CN | $74M-46.4% | $138.1M+13.4% | $121.8M+6.2% | $114.7M+13.3% | $101.2M-11.1% | |
| DE | $62.7M-40.6% | $105.5M+48.0% | $71.3M+20.6% | $59.1M-3.3% | $61.1M-29.0% | |
| Europe Excluding Germany | $258.9M-4.6% | $271.5M+12.6% | $241.2M+13.0% | $213.4M-4.8% | $224.1M-21.9% | |
| Other Country | $71.2M-3.8% | $74M+6.5% | $69.5M+16.0% | $59.9M-9.5% | $66.2M-1.9% | |
| US | $221.9M-1.4% | $225M-0.4% | $226M+1.4% | $222.9M+2.5% | $217.4M-16.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Bruker break its business down?
- Bruker (BRKR) reports revenue by business across 4 parts — Bsi Biospin, Bsi Calid, Bsi Nano and Energy And Supercon Technologies. Each is extracted from the segment footnotes and tracked over time.
- Where does Bruker's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Bruker's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
